Anna Kjerstine Rosenmai
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Anna Kjerstine Rosenmai has a total of 116 co-authors. Here are the top co-authors by number of shared publications:
- Anne Marie Vinggaard
National Food Institute, Technical University of Denmark, 2800 Kongens Lyngby, Denmark
10 shared publications - Terje Svingen
National Food Institute, Technical University of Denmark, Kgs. Lyngby, Denmark
9 shared publications - Agneta Oskarsson
Department of Animal Biosciences, Swedish University of Agricultural Sciences, Box 7023, Uppsala SE-750 07, Sweden; BioCell Analytica, Ulls väg 29C, Uppsala SE-756 51, Sweden
7 shared publications - Johan Lundqvist
Department of Animal Biosciences, Swedish University of Agricultural Sciences, PO Box 7023, Uppsala 750 07, Sweden
6 shared publications - Camilla Taxvig
Division of Diet, Disease Prevention and Toxicology, National Food Institute, Technical University of Denmark, Lyngby, Denmark
5 shared publications Geeta Mandava
Department of Biomedical Sciences and Veterinary Public Health, Swedish University of Agricultural Sciences, Box 7028, SE-750 07, Uppsala, Sweden
3 shared publications
Latest Publications
- Open Access
Isotretinoin use is associated with persistent alterations in male reproductive function
Background Isotretinoin (ISO) is a systemic retinoid widely used for the treatment of acne vulgaris , yet its potential effects on male reproductive function remain unclear with previous studies reporting inconsistent findings. Methods and finding We conducted a multi-model study combining data from the Danish Young Men Study (DYMS) cohort with ex vivo cultured human testis tissue and an in vitro Retinoic Acid Receptor alpha (RARα) reporter gene assay. In the DYMS cohort semen parameters and reproductive hormone concentrations assessed on a specific examination day were compared between ISO-users (n=322) and non-users (n=4,065). Ex vivo human testis tissue was exposed to ISO and RA for 96 hours to assess changes in hormone secretion and germ cell dynamics, while the in vitro RARα assay evaluated ISO for effects on RA-induced RARα-signaling. In the DYMS cohort, ISO use was associated with reduced FSH concentrations, higher inhibin B/FSH ratio, and elevated estradiol concentrations, along non-significant tendencies of lower sperm counts. These associations persisted even after cessation of ISO use but were not evident in men first initiating ISO use 1 year after their examination date. In the ex vivo testis tissue, ISO exposure altered hormone secretion, including increased testosterone, but did not affect germ cell proliferation or apoptosis. ISO also inhibited RA-induced RARα-signaling in vitro in a competitive manner. Conclusions These findings suggests that ISO-use may influence male reproductive function, potentially with persistent effects. Further randomized clinical trials are needed to validate these effects.
Open AccessIsotretinoin use is associated with persistent alterations in male reproductive function
Background Isotretinoin (ISO) is a systemic retinoid widely used for the treatment of acne vulgaris , yet its potential effects on male reproductive function remain unclear with previous studies reporting inconsistent findings. Methods and finding We conducted a multi-model study combining data from the Danish Young Men Study (DYMS) cohort with ex vivo cultured human testis tissue and an in vitro Retinoic Acid Receptor alpha (RARα) reporter gene assay. In the DYMS cohort semen parameters and reproductive hormone concentrations assessed on a specific examination day were compared between ISO-users (n=322) and non-users (n=4,065). Ex vivo human testis tissue was exposed to ISO and RA for 96 hours to assess changes in hormone secretion and germ cell dynamics, while the in vitro RARα assay evaluated ISO for effects on RA-induced RARα-signaling. In the DYMS cohort, ISO use was associated with reduced FSH concentrations, higher inhibin B/FSH ratio, and elevated estradiol concentrations, along non-significant tendencies of lower sperm counts. These associations persisted even after cessation of ISO use but were not evident in men first initiating ISO use 1 year after their examination date. In the ex vivo testis tissue, ISO exposure altered hormone secretion, including increased testosterone, but did not affect germ cell proliferation or apoptosis. ISO also inhibited RA-induced RARα-signaling in vitro in a competitive manner. Conclusions These findings suggests that ISO-use may influence male reproductive function, potentially with persistent effects. Further randomized clinical trials are needed to validate these effects.
- Open Access
- 22 September 2025
- Published by Elsevier in Toxicology and Applied Pharmacology
- Vol. 505, 117577
In vitro disruption of the retinoic acid signaling pathway by industrial chemicals and pharmaceuticals
- 22 September 2025
- Published by Elsevier in Toxicology and Applied Pharmacology
- Vol. 505, 117577
Open AccessIn vitro disruption of the retinoic acid signaling pathway by industrial chemicals and pharmaceuticals
- Open Access
- 15 July 2025
- Published by Elsevier in Toxicology in Vitro
- Vol. 109, 106108
Testing chemicals for CYP19 inhibition: Comparison of a modified H295R steroidogenesis assay to a commercial fluorometric enzyme inhibition kit
- 15 July 2025
- Published by Elsevier in Toxicology in Vitro
- Vol. 109, 106108
Open AccessTesting chemicals for CYP19 inhibition: Comparison of a modified H295R steroidogenesis assay to a commercial fluorometric enzyme inhibition kit
- Open Access
- 14 October 2024
- Published by Elsevier in Environmental Pollution
- Vol. 363 (Pt 1) , 125117
Perinatal exposure to environmental chemicals that disrupt thyroid function can perturb testis development
- 14 October 2024
- Published by Elsevier in Environmental Pollution
- Vol. 363 (Pt 1) , 125117
Open AccessPerinatal exposure to environmental chemicals that disrupt thyroid function can perturb testis development
- Open Access
- 6 February 2024
- Published by Elsevier in Toxicology and Applied Pharmacology
- Vol. 484, 116843
In vitro assessment of potential endocrine disrupting activities of chlorinated paraffins of various chain lengths
- 6 February 2024
- Published by Elsevier in Toxicology and Applied Pharmacology
- Vol. 484, 116843
Open AccessIn vitro assessment of potential endocrine disrupting activities of chlorinated paraffins of various chain lengths
- Open Access
- 1 April 2022
- Published by Elsevier in Environmental Pollution
- Vol. 304, 119242
Using alternative test methods to predict endocrine disruption and reproductive adverse outcomes: do we have enough knowledge?
- 1 April 2022
- Published by Elsevier in Environmental Pollution
- Vol. 304, 119242
Open AccessUsing alternative test methods to predict endocrine disruption and reproductive adverse outcomes: do we have enough knowledge?
- Open Access
- 1 September 2021
- Published by Elsevier in Chemosphere
- Vol. 279, 130624
Developmental effects of PFOS, PFOA and GenX in a 3D human induced pluripotent stem cell differentiation model
- 1 September 2021
- Published by Elsevier in Chemosphere
- Vol. 279, 130624
Open AccessDevelopmental effects of PFOS, PFOA and GenX in a 3D human induced pluripotent stem cell differentiation model
- 1 January 2021
- Published by Elsevier in Chemosphere
- Vol. 263, 127703
Organophosphate ester flame retardants have antiandrogenic potential and affect other endocrine related endpoints in vitro and in silico
- 1 January 2021
- Published by Elsevier in Chemosphere
- Vol. 263, 127703
Organophosphate ester flame retardants have antiandrogenic potential and affect other endocrine related endpoints in vitro and in silico
- Open Access
- 22 July 2020
- Published by Springer Nature in Archives of Toxicology
- Vol. 94 (11) , 3831-3846
A novel human pluripotent stem cell-based assay to predict developmental toxicity
There is a great need for novel in vitro methods to predict human developmental toxicity to comply with the 3R principles and to improve human safety. Human-induced pluripotent stem cells (hiPSC) are ideal for the development of such methods, because they are easy to retrieve by conversion of adult somatic cells and can differentiate into most cell types of the body. Advanced three-dimensional (3D) cultures of these cells, so-called embryoid bodies (EBs), moreover mimic the early developing embryo. We took advantage of this to develop a novel human toxicity assay to predict chemically induced developmental toxicity, which we termed the PluriBeat assay. We employed three different hiPSC lines from male and female donors and a robust microtiter plate-based method to produce EBs. We differentiated the cells into cardiomyocytes and introduced a scoring system for a quantitative readout of the assay—cardiomyocyte contractions in the EBs observed on day 7. Finally, we tested the three compounds thalidomide (2.3–36 µM), valproic acid (25–300 µM), and epoxiconazole (1.3–20 µM) on beating and size of the EBs. We were able to detect the human-specific teratogenicity of thalidomide and found the rodent toxicant epoxiconazole as more potent than thalidomide in our assay. We conclude that the PluriBeat assay is a novel method for predicting chemicals’ adverse effects on embryonic development.
- 22 July 2020
- Published by Springer Nature in Archives of Toxicology
- Vol. 94 (11) , 3831-3846
Open AccessA novel human pluripotent stem cell-based assay to predict developmental toxicity
There is a great need for novel in vitro methods to predict human developmental toxicity to comply with the 3R principles and to improve human safety. Human-induced pluripotent stem cells (hiPSC) are ideal for the development of such methods, because they are easy to retrieve by conversion of adult somatic cells and can differentiate into most cell types of the body. Advanced three-dimensional (3D) cultures of these cells, so-called embryoid bodies (EBs), moreover mimic the early developing embryo. We took advantage of this to develop a novel human toxicity assay to predict chemically induced developmental toxicity, which we termed the PluriBeat assay. We employed three different hiPSC lines from male and female donors and a robust microtiter plate-based method to produce EBs. We differentiated the cells into cardiomyocytes and introduced a scoring system for a quantitative readout of the assay—cardiomyocyte contractions in the EBs observed on day 7. Finally, we tested the three compounds thalidomide (2.3–36 µM), valproic acid (25–300 µM), and epoxiconazole (1.3–20 µM) on beating and size of the EBs. We were able to detect the human-specific teratogenicity of thalidomide and found the rodent toxicant epoxiconazole as more potent than thalidomide in our assay. We conclude that the PluriBeat assay is a novel method for predicting chemicals’ adverse effects on embryonic development.